XML 69 R66.htm IDEA: XBRL DOCUMENT v2.4.0.8
Guarantor Financial Information (Condensed Consolidated Statements of Cash Flows) (Details) (USD $)
In Thousands, unless otherwise specified
 3 Months Ended
Mar. 29, 2014
Mar. 30, 2013
Cash flows from operating activities:    
Net income/ (loss) $ (51,006) $ 32,405
Earnings in investments in subsidiaries 0 0
Other operating cash flows 20,502 27,077
Net cash provided/(used) by operating activities (30,504) 59,482
Cash flows from investing activities:    
Capital expenditures (51,360) (26,392)
Acquisitions, net of cash acquired (2,081,690) 0
Investment in unconsolidated subsidiary 0 (12,535)
Note receivable from affiliates 0  
Gross proceeds from disposal of property, plant and equipment and other assets 1,324 412
Proceeds from insurance settlements 0 0
Payments related to routes and other intangibles (6,812) (613)
Net cash used by investing activities (2,138,538) (39,128)
Cash flows from financing activities:    
Proceeds from long-term debt 1,797,509 0
Payments on long-term debt (263,971) (21)
Borrowings from revolving credit facility 223,310 0
Payments on revolving credit facility (273,474) 0
Deferred loan costs (38,786) 0
Issuance of common stock 2,504 16
Contributions from parent 0 0
Minimum withholding taxes paid on stock awards (4,709) (2,523)
Excess tax benefits from stock-based compensation 960 702
Net cash provided/ (used) by financing activities 1,443,343 (1,826)
Effect of exchange rate changes on cash and cash equivalents (1,736) 0
Net increase/(decrease) in cash and cash equivalents (727,435) 18,528
Cash and cash equivalents at beginning of period 870,857 103,249
Cash and cash equivalents at end of period 143,422 121,777
Issuer [Member]
    
Cash flows from operating activities:    
Net income/ (loss) (51,006) 32,405
Earnings in investments in subsidiaries (11,361) (29,718)
Other operating cash flows 35,205 46,516
Net cash provided/(used) by operating activities (27,162) 49,203
Cash flows from investing activities:    
Capital expenditures (14,754) (13,173)
Acquisitions, net of cash acquired 0 0
Investment in unconsolidated subsidiary (1,483,007) (12,560)
Note receivable from affiliates 0  
Gross proceeds from disposal of property, plant and equipment and other assets 298 131
Proceeds from insurance settlements 0 0
Payments related to routes and other intangibles (6,812) (613)
Net cash used by investing activities (1,504,275) (26,215)
Cash flows from financing activities:    
Proceeds from long-term debt 1,100,000  
Payments on long-term debt (250,000) 0
Borrowings from revolving credit facility 122,445  
Payments on revolving credit facility (207,445)  
Deferred loan costs (35,292)  
Issuance of common stock 2,504 16
Contributions from parent 0 0
Minimum withholding taxes paid on stock awards (4,709) (2,523)
Excess tax benefits from stock-based compensation 960 702
Net cash provided/ (used) by financing activities 728,463 (1,805)
Effect of exchange rate changes on cash and cash equivalents 0  
Net increase/(decrease) in cash and cash equivalents (802,974) 21,183
Cash and cash equivalents at beginning of period 857,267 96,945
Cash and cash equivalents at end of period 54,293 118,128
Guarantors [Member]
    
Cash flows from operating activities:    
Net income/ (loss) 34,630 30,435
Earnings in investments in subsidiaries 0 0
Other operating cash flows (11,156) (20,600)
Net cash provided/(used) by operating activities 23,474 9,835
Cash flows from investing activities:    
Capital expenditures (16,332) (13,219)
Acquisitions, net of cash acquired (645) 0
Investment in unconsolidated subsidiary (2,217,686) 0
Note receivable from affiliates (204,074)  
Gross proceeds from disposal of property, plant and equipment and other assets 857 281
Proceeds from insurance settlements 0 0
Payments related to routes and other intangibles 0 0
Net cash used by investing activities (2,437,880) (12,938)
Cash flows from financing activities:    
Proceeds from long-term debt 0  
Payments on long-term debt (22) (21)
Borrowings from revolving credit facility 0  
Payments on revolving credit facility 0  
Deferred loan costs 0  
Issuance of common stock 0 0
Contributions from parent 2,421,762 0
Minimum withholding taxes paid on stock awards 0 0
Excess tax benefits from stock-based compensation 0 0
Net cash provided/ (used) by financing activities 2,421,740 (21)
Effect of exchange rate changes on cash and cash equivalents 0  
Net increase/(decrease) in cash and cash equivalents 7,334 (3,124)
Cash and cash equivalents at beginning of period 6,117 5,577
Cash and cash equivalents at end of period 13,451 2,453
Non-guarantors [Member]
    
Cash flows from operating activities:    
Net income/ (loss) (23,269) (717)
Earnings in investments in subsidiaries 0 0
Other operating cash flows (3,547) 1,161
Net cash provided/(used) by operating activities (26,816) 444
Cash flows from investing activities:    
Capital expenditures (20,274) 0
Acquisitions, net of cash acquired (2,081,045) 0
Investment in unconsolidated subsidiary (7,688,504) (12,535)
Note receivable from affiliates 204,074  
Gross proceeds from disposal of property, plant and equipment and other assets 169 0
Proceeds from insurance settlements 0 0
Payments related to routes and other intangibles 0 0
Net cash used by investing activities (9,585,580) (12,535)
Cash flows from financing activities:    
Proceeds from long-term debt 697,509  
Payments on long-term debt (13,949) 0
Borrowings from revolving credit facility 100,865  
Payments on revolving credit facility (66,029)  
Deferred loan costs (3,494)  
Issuance of common stock 0 0
Contributions from parent 8,967,435 12,560
Minimum withholding taxes paid on stock awards 0 0
Excess tax benefits from stock-based compensation 0 0
Net cash provided/ (used) by financing activities 9,682,337 12,560
Effect of exchange rate changes on cash and cash equivalents (1,736)  
Net increase/(decrease) in cash and cash equivalents 68,205 469
Cash and cash equivalents at beginning of period 7,473 727
Cash and cash equivalents at end of period 75,678 1,196
Eliminations [Member]
    
Cash flows from operating activities:    
Net income/ (loss) (11,361) (29,718)
Earnings in investments in subsidiaries 11,361 29,718
Other operating cash flows 0 0
Net cash provided/(used) by operating activities 0 0
Cash flows from investing activities:    
Capital expenditures 0 0
Acquisitions, net of cash acquired 0 0
Investment in unconsolidated subsidiary 11,389,197 12,560
Note receivable from affiliates 0  
Gross proceeds from disposal of property, plant and equipment and other assets 0 0
Proceeds from insurance settlements 0 0
Payments related to routes and other intangibles 0 0
Net cash used by investing activities 11,389,197 12,560
Cash flows from financing activities:    
Proceeds from long-term debt 0  
Payments on long-term debt 0 0
Borrowings from revolving credit facility 0  
Payments on revolving credit facility 0  
Deferred loan costs 0  
Issuance of common stock 0 0
Contributions from parent (11,389,197) (12,560)
Minimum withholding taxes paid on stock awards 0 0
Excess tax benefits from stock-based compensation 0 0
Net cash provided/ (used) by financing activities (11,389,197) (12,560)
Effect of exchange rate changes on cash and cash equivalents 0  
Net increase/(decrease) in cash and cash equivalents 0 0
Cash and cash equivalents at beginning of period 0 0
Cash and cash equivalents at end of period $ 0 $ 0